ArticleJournal of medicinal chemistry2017

Novel Selective Estrogen Receptor Downregulators (SERDs) Developed against Treatment-Resistant Breast Cancer.

Rui Xiong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.